Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

October 31, 2002

Study Completion Date

August 31, 2003

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

FOLFOX regimen

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (22)

29605

Cancer Centers of the Carolinas, Greenville

40503

Central Baptist Hospital, Lexington

43214

Grant/Riverside Methodist Hospitals, Columbus

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

46617

Michiana Hematology/Oncology P.C., South Bend

49085

Lakeland Medical Center - St. Joseph, Saint Joseph

60068

Lutheran General Cancer Care Center, Park Ridge

60153

Loyola University Medical Center, Maywood

60201

Evanston Northwestern Health Care, Evanston

60426

Ingalls Memorial Hospital, Harvey

60525

Columbia LaGrange Memorial Hospital, LaGrange

60612

University of Illinois at Chicago, Chicago

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Cancer Care Specialists of Central Illinois, S.C., Decatur

62701

Central Illinois Hematology Oncology Center, Springfield

06520-8028

Yale Comprehensive Cancer Center, New Haven

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

14263-0001

Roswell Park Cancer Institute, Buffalo

00936-5067

University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00004127 - Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | Biotech Hunter | Biotech Hunter